Literature DB >> 27612992

The comparison of animal models for premature ovarian failure established by several different source of inducers.

Ting Zhang1, Dawei Yan1, Yang Yang1, Aicui Ma1, Lei Li1, Zhonghui Wang1, Qi Pan1, Zuyue Sun2.   

Abstract

The objective of this study was to compare premature ovarian failure animal models established by several different source of inducers. Female ICR mice, KM mice, and SD rats were treated by cyclophosphamide at 120 mg/kg, busulfan at 12 mg/kg, cisplatin at 3 or 4 mg/kg, 4-vinylcyclohexene diepoxide at 160 mg/kg, 35% galactose food pellet, and tripterygium glycosides at 50 mg/kg, respectively. Parameters were analyzed by body weight, serum concentration level of related hormones, ovarian and uterine pathological examination. The results indicated the body weight of mice increased very slowly following single dose of cyclophosphamide (p < 0.05) with damaged ovary; repeated doses of cisplatin could induce body weight significantly decreased (p < 0.01) with a rising trend of serum LH concentration, declining tendency of serum E2 concentration and injured ovary and uterus; 4-vinylcyclohexene diepoxide also hindered the mice growing (p < 0.05) with damaged ovary and uterus; the body weight of mice feed by 35% galactose food pellet increased slowly (p < 0.05) with dramatically higher serum concentration level of galactose, albumin, and total protein (p < 0.001) and injured ovary. Busulfan and tripterygium glycosides did not present obvious evidences. In conclusion, the inducers presented their respective features in such animal models and should be appropriately applied in preventive methods. Copyright Â
© 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  4-Vinylcyclohexene diepoxide; Busulfan; Chemotherapy; Cisplatin; Cyclophosphamide; Galactose; Premature ovarian failure; Tripterygium glycosides

Mesh:

Substances:

Year:  2016        PMID: 27612992     DOI: 10.1016/j.yrtph.2016.09.002

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  15 in total

1.  Characterizing the effects of tonic 17β-estradiol administration on spatial learning and memory in the follicle-deplete middle-aged female rat.

Authors:  Stephanie V Koebele; Sarah E Mennenga; Mallori L Poisson; Lauren T Hewitt; Shruti Patel; Loretta P Mayer; Cheryl A Dyer; Heather A Bimonte-Nelson
Journal:  Horm Behav       Date:  2020-09-25       Impact factor: 3.587

2.  Induction of a rat model of premature ovarian insufficiency using D-galactose feeding during the critical periods of development: A pilot study.

Authors:  Marzieh Rostami Dovom; Mahsa Noroozzadeh; Nariman Mosaffa; Abbas Piryaei; Azita Zadevakili; Mohammad Amin Abdollahifar; Fahimeh Ramezani Tehrani
Journal:  Int J Reprod Biomed       Date:  2022-05-23

3.  Optimized platelet rich plasma releasate (O-rPRP) repairs galactosemia-induced ovarian follicular loss in rats by activating mTOR signaling and inhibiting apoptosis.

Authors:  Wesam El Bakly; Marwa Medhat; Mohamed Shafei; Reham Tash; Mohamed Elrefai; Yousef Shoukry; Nesreen Nabil Omar
Journal:  Heliyon       Date:  2020-09-21

4.  Induced premature ovarian insufficiency by using D galactose and its effects on reproductive profiles in small laboratory animals: a systematic review.

Authors:  Marzieh Rostami Dovom; Mahsa Noroozzadeh; Nariman Mosaffa; Azita Zadeh-Vakili; Abbas Piryaei; Fahimeh Ramezani Tehrani
Journal:  J Ovarian Res       Date:  2019-10-16       Impact factor: 4.234

5.  Premature Ovarian Insufficiency (POI) Induced by Dynamic Intensity Modulated Radiation Therapy via P13K-AKT-FOXO3a in Rat Models.

Authors:  Lianli He; Xiaoqin Long; Nixiao Yu; Yajun Li; Xiaoyun Liu; Xiaoju Cheng
Journal:  Biomed Res Int       Date:  2021-06-29       Impact factor: 3.411

6.  Research on Establishment of Abnormal Phlegmatic Syndrome with Premature Ovarian Failure Rat Model and Effects of Balgham Munziq Treatment.

Authors:  Muladili Yuemaier; Mayire Tuerhong; Abulizi Keremu; Nafeisha Kadeer; Ayiguzhali Aimaiti; Xilinguli Wushouer; Adilijiang Yiming; Xiamixinuer Yilike
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-26       Impact factor: 2.629

7.  Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure.

Authors:  Khadijeh Bahrehbar; Mojtaba Rezazadeh Valojerdi; Fereshteh Esfandiari; Rouhollah Fathi; Seyedeh-Nafiseh Hassani; Hossein Baharvand
Journal:  World J Stem Cells       Date:  2020-08-26       Impact factor: 5.326

8.  Establishment of Effective Mouse Model of Premature Ovarian Failure Considering Treatment Duration of Anticancer Drugs and Natural Recovery Time.

Authors:  Eun Hee Lee; Si Eun Han; Min Jung Park; Hyeon Jung Kim; Hwi Gon Kim; Chang Woon Kim; Bo Sun Joo; Kyu Sup Lee
Journal:  J Menopausal Med       Date:  2018-12-31

Review 9.  Impact of Ovarian Aging in Reproduction: From Telomeres and Mice Models to Ovarian Rejuvenation.

Authors:  Alba María Polonio; Lucía Chico-Sordo; Isabel Córdova-Oriz; Marta Medrano; Juan A García-Velasco; Elisa Varela
Journal:  Yale J Biol Med       Date:  2020-09-30

10.  Clinically Used Hormone Formulations Differentially Impact Memory, Anxiety-Like, and Depressive-Like Behaviors in a Rat Model of Transitional Menopause.

Authors:  Stephanie V Koebele; Ryoko Hiroi; Zachary M T Plumley; Ryan Melikian; Alesia V Prakapenka; Shruti Patel; Catherine Carson; Destiney Kirby; Sarah E Mennenga; Loretta P Mayer; Cheryl A Dyer; Heather A Bimonte-Nelson
Journal:  Front Behav Neurosci       Date:  2021-07-21       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.